Recent advances on antimony(III/V) compounds with potential activity against tumor cells
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 153, 293-305
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Metallodrugs in Medicinal Inorganic ChemistryChemical Reviews, 2014
- Study on single crystal structure of the antimony(III) bromide complex with 3-methyl-2-mercaptobenzothiazole and biological activity of some antimony(III) bromide complexes with thioamidesMedicinal Chemistry Research, 2011
- Interaction of antimony(III) chloride with thiourea, 2-mercapto-5-methyl-benzimidazole, 3-methyl-2-mercaptobenzothiazole, 2-mercaptopyrimidine, and 2-mercaptopyridineJournal of Coordination Chemistry, 2011
- Structural Motifs and Biological Studies of New Antimony(III) Iodide Complexes with ThionesInorganic Chemistry, 2009
- New Antimony(III) Bromide Complexes with Thioamides: Synthesis, Characterization, and Cytostatic PropertiesInorganic Chemistry, 2009
- Perspectives of antimony compounds in oncologyActa Pharmacologica Sinica, 2008
- Synthesis, Structural Characterization, and Biological Studies of New Antimony(III) Complexes with Thiones. The Influence of the Solvent on the Geometry of the ComplexesInorganic Chemistry, 2007
- Synthesis and characterization of new water stable antimony(III) complex with pyrimidine-2-thione and in vitro biological studyInorganica Chimica Acta, 2005
- Antimony and bismuth compounds in oncologyCritical Reviews in Oncology/Hematology, 2002
- LeishmaniasisThe Lancet, 1999